Mesenchymal Cell News Volume 14.42 | Oct 25 2022

    0
    27








    2022-10-24 | MESCN 14.42


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 14.42 – 25 October, 2022
    TOP STORY

    Biocompatible Iron Oxide Nanoring-Labeled Mesenchymal Stem Cells: An Innovative Magnetothermal Approach for Cell Tracking and Targeted Stroke Therapy

    Investigators described an advanced magnetothermal approach to label MSCs efficiently by local induction of heat-enhanced membrane permeability for magnetic resonance imaging tracking and targeted therapy of stroke.
    [ACS Nano]

    AbstractGraphical Abstract
    ON712CXN-Cancer-728-x-90-1
    PUBLICATIONSRanked by the impact factor of the journal

    Characterization of the Proteins Secreted by Equine Muscle-Derived Mesenchymal Stem Cells Exposed to Cartilage Explants in Osteoarthritis Model

    Researchers characterized the secreted proteins of muscle-derived MSCs (mdMSCs) in an in vitro model of osteoarthritis to evaluate the putative clinical interest of mdMSCs as cell therapy for joint diseases like osteoarthritis.
    [Stem Cell Reviews and Reports]

    Full Article

    Role of Heparan Sulfate in Vasculogenesis of Dental Pulp Stem Cells

    The authors investigated the role of heparan sulfate in endothelial differentiation and vasculogenesis of dental pulp stem cell.
    [Journal of Dental Research]

    Abstract

    Substrate Adhesion Determines Migration during Mesenchymal Cell Condensation in Chondrogenesis

    Scientists focused on the mechanisms of cell migration during mesenchymal cell condensation and the effects of matrix adherence.
    [Journal of Cell Science]

    Abstract

    Single-Cell RNA Sequencing Reveals Different Signatures of Mesenchymal Stromal Cell Pluripotent-Like and Multipotent Populations

    Human bone marrow-MSCs were separated into pluripotent-like SSEA-3(+) Muse cells and multipotent SSEA-3(-) MSCs and were subjected to single-cell RNA sequencing analysis.
    [iScience]

    AbstractGraphical Abstract

    High Throughput Screening of Mesenchymal Stem Cell Lines Using Deep Learning

    Investigators proposed an end-to-end deep learning framework for functional screening of MSC lines using live-cell microscopic images of MSC populations.
    [Scientific Reports]

    Full Article

    Enforced Mesenchymal Stem Cell Tissue Colonization Counteracts Immunopathology

    Acute graft-versus-host disease induced the expression of E-selectin within lesional endothelial beds, and tissue-specific recruitment of systemically administered host-derived MSCs was achieved by enforced expression of HCELL, a CD44 glycoform that is a potent E-selectin ligand.
    [npj Regenerative Medicine]

    Full Article

    Therapy Free of Cells vs Human Mesenchymal Stem Cells from Umbilical Cord Stroma to Treat the Inflammation in OA

    Scientists compared the efficacy of two treatments, MSC with their miR-21 inhibited through lentiviral transfection and their extracellular vesicles, against inflammation in a new osteoarthritis (OA) animal model.
    [Cellular and Molecular Life Sciences]

    Full ArticleGraphical Abstract

    Combined Transplantation of Human MSCs and ECFCs Improves Cardiac Function and Decrease Cardiomyocyte Apoptosis after Acute Myocardial Infarction

    Investigators examined the combination therapy of human mesenchymal stromal cells (MSCs) and endothelial colony-forming cells (ECFCs) to reduce the early ischemic damage and enhance angiogenesis in a pre-clinical model of acute myocardial infarction.
    [Stem Cell Reviews and Reports]

    Full Article

    Mesenchymal Stem Cell Aggregation Mediated by Integrin α4/VCAM-1 after Intrathecal Transplantation in MCAO Rats

    Rats with or without middle cerebral artery occlusion (MCAO) received intrathecal injections of 2D cultured MSCs, 3D cultured MSCs, or an equal volume of artificial cerebrospinal fluid.
    [Stem Cell Research & Therapy]

    Full Article

    Stay up-to-date with the latest stem cell research by listening to the Stem Cell Podcast!
    REVIEWS

    Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control

    The authors focus on the main resources of MSCs, underlying therapeutic mechanisms, clinical applications, and efforts made to improve MSC-based cell therapy efficiency.
    [Stem Cells International]

    Full Article
    INDUSTRY AND POLICY NEWS

    FDA Allows Phase IIb Long COVID Study to Treat Patients Suffering from Long-COVID

    Pulthera, LLC has received notice from the US FDA Investigational New Drug that it can proceed with “A Phase IIb, Study to Assess the Efficacy, Safety, and Tolerability of Intravenous Allogenic Bone Marrow-derived MSCs in Subjects with Dyspnea Associated with Post-acute Sequelae of SARS-CoV-2 Infection.”
    [Pulthera, LLC]

    Press Release
    FEATURED EVENT

    4th Growth Factors in Regeneration and Regenerative Medicine Conference

    February 9 – 12, 2023
    Cancun, Mexico

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Oral Immunology and Tissue Degenerative Processes

    Ume̴, Sweden РUme̴ University

    Postdoctoral Researcher – Childhood Oncology

    Karolinska Institutet – Solna, Sweden

    PhD – Cartilage Organoids

    Eindhoven University of Technology – Eindhoven, Netherlands

    Research Professor – Tissue Regeneration Engineering

    Institute of Tissue Regeneration Engineering – Cheonan, South Korea

    Assistant/Associate Faculty Position – Cancer Research

    University of Colorado Denver – Aurora, Colorado, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter